Winning SSD benefits is based on the impact of your specific medical condition on your ability to work
The future of these medications is bright
These include: Nausea (very common, affecting more than 1 in 10 people) Diarrhoea (common, affecting up to 1 in 10 people) Vomiting (common) Constipation (common) Abdominal pain and discomfort (common) These gastrointestinal effects create the conditions for dehydration , which subsequently causes urine to become concentrated and darker
For severe obesity specifically, these are not comparable outcomes
Results of a secondary analysis found that semaglutide may help decrease the risk of death from any cause, death from cardiovascular causes, combined heart failure outcomes, and major adverse cardiovascular events after just six months of receiving semaglutide
its differentiator is mechanistic (amylin + GLP-1), not a decisive efficiency advantage